Quantcast
AAN Risks Of Opioids Outweigh Benefits For Headache Low Back

AAN: Risks Of Opioids Outweigh Benefits For Headache, Low Back Pain, Other Conditions

Rachel Seroka, American Academy of Neurology According to a new position statement from the American Academy of Neurology (AAN), the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in...

Latest Ketones Stories

2014-09-30 16:28:37

JOHNSTOWN, Pa., Sept. 30, 2014 /PRNewswire-USNewswire/ -- Governor Tom Corbett was joined today by Senator Dominic Pileggi (R-Delaware) on the University of Pittsburgh at Johnstown campus to sign into law life-saving legislation that will help to reverse heroin overdoses in Pennsylvania. At the event, he also approved recommendations from a working group established in May that will improve the state's response to the growing heroin and opoid addiction and overdose crisis. Opioids are a...

2014-09-30 08:33:33

ST. PAUL, Minn., Sept. 30, 2014 /PRNewswire/ -- In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g. opioids).(1 )Clinical treatments for opioid dependence include detoxification or maintenance treatment, which entails the use of buprenorphine, buprenorphine/naloxone, naltrexone or methadone. The patterns and costs of these treatments are important when developing and improving care management programs, according to two studies by pharmacy...

2014-09-30 08:32:31

KemPharm's Intellectual Property Estate Now Includes Composition of Matter Patents for Two Ligand Activated Technology (LAT) Opioid Prodrugs - KP511 and KP201 CORALVILLE, Iowa, Sept. 30, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,816,083 to KemPharm...

2014-09-27 23:00:13

PAINWeekEnd Denver will be convened on Saturday, October 4, at the Denver Marriott City Center at 1701 California Street. Montclair, NJ (PRWEB) September 28, 2014 There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around. What can primary care clinicians do to meet the challenges of this growing public health issue? Attend PAINWeekEnd Denver on Saturday, October 4, at...

2014-09-24 23:00:43

In its latest blog post, A Forever Recovery, an open-ended drug and alcohol treatment program that gets clients off to a great start and gives them a solid foundation in recovery they can believe in, is focusing on key facts about the history of oxycodone. Battle Creek, MI (PRWEB) September 25, 2014 In its latest blog post, A Forever Recovery, an open-ended drug and alcohol treatment program that gets clients off to a great start and gives them a solid foundation in recovery they can...

2014-09-24 08:29:17

National Fed Up! Coalition Holds Second Major Rally as Death Toll Climbs from Opioid Epidemic WASHINGTON, Sept. 24, 2014 /PRNewswire-USNewswire/ -- On Sunday, September 28, 2014, a coalition of consumer advocacy organizations, drug prevention groups, medical experts and addiction treatment providers will hold the second annual Fed Up! Rally to call for an immediate, coordinated and comprehensive federal response to the epidemic of opioid addiction and overdose deaths. The Rally will...

2014-09-24 08:28:08

95 of 180 Patients Enrolled; Additional Patients Screened, Awaiting Randomization PRINCETON, N.J., Sept. 24, 2014 /PRNewswire/ -- Braeburn Pharmaceuticals today announced that it has surpassed the midway point for patient enrollment in its Phase 3 study of Probuphine(®), which began in July of 2014. Probuphine is a buprenorphine subdermal implant being studied for the maintenance treatment of opioid dependence. Completion of the study is on track for the middle of 2015, with...

2014-09-23 08:31:03

KemPharm Joins CLADD in Support of Legislation from Health Canada to Encourage More Responsible Development and Administration of Prescription Opioids CORALVILLE, Iowa, Sept. 23, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it received a No Objection Letter (NOL) from Health Canada to begin clinical trials in Canada for its lead...

2014-09-21 23:01:43

LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019” to its store. Inquire Before Buying at http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=12380 Dallas, TX (PRWEB) September 21, 2014 Market Research Report on Global and Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Fenofibrate (CAS...

2014-09-16 08:32:01

Big Cities Health Coalition Urges Immediate Federal Action WASHINGTON, Sept. 16, 2014 /PRNewswire/ -- Today, the top public health officials from Boston, Chicago, and New York City, all members of the Big Cities Health Coalition, arrived on Capitol Hill with a grim report on the state of opioid addiction and overdose in our nation's cities - and a request for federal action to be taken immediately. "Opioid addiction is one of the most challenging problems for health departments to...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related